Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
The original article [1] contains an error in the y-axes of Fig. 8’s sub-figures whereby ‘CSF’ is mistakenly mentioned instead of ‘serum’.
Main Authors: | Mylene Huebecker, Elizabeth B. Moloney, Aarnoud C. van der Spoel, David A. Priestman, Ole Isacson, Penelope J. Hallett, Frances M. Platt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Molecular Neurodegeneration |
Online Access: | https://doi.org/10.1186/s13024-019-0355-z |
Similar Items
-
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Mylene Huebecker, et al.
Published: (2019-11-01) -
Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
by: Aleksandra Somogyi, et al.
Published: (2018-02-01) -
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
by: Penelope J. Hallett, et al.
Published: (2019-07-01) -
The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress
by: Elizabeth B. Moloney, et al.
Published: (2018-12-01) -
Ganglioside Metabolism and Parkinson's Disease
by: John Forsayeth, et al.
Published: (2018-02-01)